Skip to main content
Navigate Up
Sign In

Brain metastases common during treatment with crizotinib for ROS1-postive NSCLC

“This study clarifies the need to develop targeted therapies with brain penetration against these oncogene-addicted lung cancers,” said Tejas Patil, oncology fellow at University of Colorado Cancer Center and instructor at CU School of Medicine.